简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2015-10-29 17:53 Egon Zehnder Announces New Global Health Practice – Egon Zehnder Health
2015-10-29 17:06 Seattle Genetics and Takeda Achieve Target Enrollment in Phase 3 ECHELON-1 Clinical Trial Evaluating ADCETRIS® (Brentuximab Vedotin) in Previously Untreated Advanced Hodgkin Lymphoma (HL)
2015-10-29 14:29 Terumo BCT Completes the First Clinical Study Reducing Malaria Transmission from Whole Blood Transfusions with Pathogen Reduction Technology
2015-10-29 10:05 Boehringer Ingelheim’s Biosimilar Candidate Demonstrated Pharmacokinetic Bioequivalence to Adalimumab
2015-10-29 09:56 CHEST: New Sub-Analyses Show Improvement in COPD Patient Outcomes with Spiolto® Respimat®
2015-10-28 17:20 Masimo Announces FDA 510(k) Clearance for MightySat™ Rx Fingertip Pulse Oximeter
2015-10-27 16:53 1abtik ag Founded to Fight Sepsis with Novel Antibody Therapeutics
2015-10-27 15:34 Pope Francis Accepts Donation of Terason uSmart® 3200T Ultrasound System for Vatican
2015-10-27 11:58 Phase 2 Maintenance Data from Oral Ozanimod TOUCHSTONE Study in Ulcerative Colitis Presented at UEG Week
2015-10-23 16:28 CE Mark Granted for Novel Cryoablation Device Aimed at Reducing the Incidence of Esophageal Cancer
2015-10-23 16:00 Quintiles and IMS Health Announce Global Collaboration to Advance the Use of Next-Generation Real-World Evidence in Late-Stage Clinical Research
2015-10-21 15:11 Quintiles Names Kevin Gordon as COO, Appoints Mike McDonnell as CFO
2015-10-21 14:43 ARxIUM Selects Silver Wing Asia-Pacific International Medical Technology Company as its Exclusive Distributor of RIVA Automated Compounding System in Mainland China
2015-10-21 14:20 Phase 2 Maintenance Data from Oral Ozanimod TOUCHSTONE Study in Ulcerative Colitis Presented at ACG Plenary Session
2015-10-21 14:00 Sinophi Healthcare Ltd: Seven China hospital deals worth £800 million focused on proton therapy to treat cancer
2015-10-20 10:00 Premier Biomedical and Auramedi Farmacêutica Agree to Explore Forming Joint Venture in Brazil
2015-10-19 16:01 FDA Approves Praxbind® (idarucizumab), Specific Reversal Agent for Pradaxa® (dabigatran etexilate)
2015-10-19 14:26 New CPR Guidelines Recommend Using Social Media and Mobile Technology to Speed Bystander CPR in Sudden Cardiac Arrests
2015-10-16 17:51 GN ReSound and Cochlear Limited Establish Smart Hearing Alliance to Develop and Commercialise Bimodal Solutions
2015-10-16 17:11 One Year on, Allianz Worldwide Care’s MyHealth App Hits 100,000 Member Claim Submissions

Business Wire Weibo

Press Releases

Latest Releases